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1. Introduction 
Muscle tissue of crustacea has a double innervation 
with excitatory and inhibitory nerve tibres. Several 
evidences have suggested that the excitatory transmitter 
is glutamic acid. They refer to the stimulation of con- 
traction by the applied drug [ 1,2] experiments of 
stimulus release [3] and effects of glutamate on mem- 
brane potentials [4]. By radioautography the uptake 
of [3H]glutamate was found to be greater at the neuro- 
muscular junction and to be enhanced by electrical 
stimulation [.5]. A considerable literature supports 
the view that y-aminobutyric acid (GABA) is the inhi- 
bitory transmitter (see [6, 71). The effect of GABA 
may be blocked by picrotoxin [8,9] and bicuculline 
[lo]. The inhibitory nerves of crustacea contain lOO- 
fold more GABA than those of the excitatory [ 1 l] 
and the synthesizing enzyme is only present in the 
former [12]. Furthermore GABA appears in the super- 
fusate after stimulation of the inhibitory nerves [ 131. 
The separation of glutamate receptors from insect 
muscle has been carried out by Lunt [ 141, using both 
the methods of solubilization by detergents [ 151 and 
the extraction with organic solvents [ 161. 
In the present work we will describe the separation 
of two hydrophobic protein fractions (i.e. proteolipids) 
one binding glutamate, the other y-aminobutyrate. 
2. Materials and methods 
Muscles of shrimps, Artemisia longinaris from the 
family Penalidae, were homogenized in 0.05 M Tris-Cl 
buffer pH 7.5; then centrifuged at 100 000 g for 
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30 min and the sediment was lyophilised. The sediment 
contained 25.6 mg total protein per g tissue [ 171. After 
extraction in chloroform-methanol (2: 1) 154.5 ,ug of 
hydrophobic protein per g tissue was separated. The 
best results were obtained after submitting the extract 
to precipitation with 4 vol of diethyl-ether at -20°C. 
The sediment had 5% of the protein and only 5% of 
the lipid phosphorus. Both the sediment and the 
supernatant were used for binding experiments and for 
the isolation of receptor proteins. The radioactive 
drugs used were: [U-14C] Lglutamic acid, 270 mCi/ 
mmole; [l-lk] y-aminobutyric acid, 3.14 mCi/mmole; 
[U-14C] L-glutamine, 45 mCi/mmole and [U-14C] L- 
aspartic acid, 23 1 mCi/mmole (all from Amersham). 
3. Results 
3.1. Binding of [14CJL-glutamate und column 
chromatography 
Preliminary binding studies, using a centrifugation- 
washing method [ 181, were carried out on homogenized 
fresh tissue incubated with [ 14C] L-glutamate, at a 
final concn. of 9 X 10W8 M. The pellets were lyophilise 
extracted with chloroform-methanol [ 161 and 
chromatographed in a Sephadex LH-20 column. The 
results obtained were identical to those shown in fig. 1, 
in which the binding was carried out directly on the 
lipid extract at a concn. of 3.6 X 10V7 M [14C]L 
glutamate. 
The hydrophobic proteins emerged in three peaks 
in the chloroform and two smaller ones in the chloro- 
form-methanol (4: 1) (fig. 1). The radioactivity 
appeared in a sharp peak between 16-26 ml of chloro- 
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Fig. 1. Chromatography on Sephadex LH-20 of the total 
hydrophobic proteins from shrimp muscle and binding of 
[ 14C] L-glutamate. 500 mg of lyophilised sediment, corre- 
sponding to 3.3 g fresh tissue, were extracted with chloro- 
form-methanol as in [ 16) The extract was treated with 
activated charcoal to eliminate the red pigment. It was then 
concentrated to 3 ml and submitted to binding with 3.6 X 10e7 
M [ 14C]L-glutamate. Observe that the radioactivity is coin- 
cident with the beginning of the protein elution. Each tube 
contains 2 ml of eluate. (See further details in the text). 
form in coincidence with the first protein fraction 
that is eluted. The amount of protein in this fraction 
is about 27 pg/g. The lipid phosphorus was eluted in a 
large peak between 16-34 ml of chloroform and a 
small peak in chloroform-methanol (4: I). Experi- 
ments of binding carried out with the supernatant of 
the ether precipitate gave similar results. The radio- 
activity now appeared with a better defined peak of 
protein eluting between 12-20 ml of chloroform. 
Control experiments done with [14C] L-glutamate 
processed in a similar way, but in the absence of extract, 
showed that the free counts appeared in the chloro- 
form-methanol (4: 1) (fig. 1). 
3.2. Binding of [14CJL-glutamate by partition 
The technique described by Weber et al. [ 191 for a 
fluorescent cholinergic probe was adapted to study 
the binding of glutamate. In the organic phase there 
were 40 pg of the protein fraction, known to bind 
this ligand, dissolved in 2 ml of 0.05 M Tris-Cl buffer 
pH 7.5 and 0.2 M NaCl. Control experiments showed 
that the partition of glutamate was 100% favorable to 
water. The binding experiments were done at concen- 
trations of free glutamate between 1.8 X lo@ and 
1 .O X lop4 M. Saturation was reached between 6.5 X 
1O-5 and 1 X 10V4 M and the binding was of 3.07 
Eluate (ml) 
Fig. 2. Chromatograohy on Sephadex LH-20 of the hydro- 
phobic proteins contained in the diethylether precipitate of 
the shrimp muscle and binding of [ 14C]GABA. 1 g of lyo- 
philized sediment was extracted as in fig. 1. The concentrated 
extract was precipitated 1:4 with diethylether at -20°C. The 
precipitate, redissolved in 3 ml of chloroform-methanol 
(2: l), was submitted to binding with 2 X 10m6 M [ 14C]GABA. 
Observe that the radioactivity appears in coincidence with a 
sharp peak of protein which does not contain lipid phosphorus. 
Each tube contains 2 ml of elutae. (See further details in the 
text.) 
pmoles/pg protein. This corresponds to the binding of 
one mole of glutamate per 320 000 g of protein. 
The specificity of this binding was investigated 
carrying similar experiments with 2.5 X 1 Ow4 M 
[14C] L-aspartate and [ 14C] L-glutamine. In both cases 
there was no binding to the protein in the lower phase. 
3.3. Binding of [14C]GABA and column chromato- 
graphy 
Preliminary experiments suggested that [14C]GABA 
was related to a hydrophobic protein fraction eluted 
at higher effluent volumes than glutamate. However, 
the most clear cut results were obtained using the ether 
precipitate. This was redissolved in 3 ml of chloro- 
form-methanol (2: 1) and [14C]GABA was added to 
a final concn. of 2 X 1 Ow6 M. After 30 min the extract 
was chromatographed in a Sephadex LH-20 column. 
As shown in fig. 2 the radioactivity appeared in coin- 
cidence with a peak of protein between 24-32 ml of 
chloroform. This peak is devoid of lipid phosphorus. 
In control experiments the free [ 14C]GABA was 
eluted at the end of the chromatogram. The ether pre- 
cipitate was apparently devoid of receptor protein for 
glutamate since it showed no binding for this ligand. 
46 
Volume 33, number 1 FEBS LETTERS June 1973 
The amount of protein binding GABA corresponds to 
2 1.5 pg/g fresh tissue. 
3.4. Saturation of the binding of (14C]GABA 
The protein fraction eluted between 24-32 ml was 
separated and submitted to binding with [14C]GABA 
in concentrations between 2.1 X 10e6 and 2.4 X lops M. 
Then the extracts were rechromatographed using small 
columns of Sephadex LH-20 (10 X 0.8 cm) which were 
eluted with chloroform. The saturation of the binding 
was reached at a concentration in between 1.5 X lo@ 
and 2.4 X 10e5 M with 12.8 pmoles/pg protein. At 
this level I mole of GABA binds to approx. 80 000 g 
of protein. 
3.5. Inhibition by bicuculline of GABA binding 
Experiments done as in sect. 3.4 using a fixed con- 
centration of [14C]GABA (i.e. 8 X lo@’ M) in the 
presence of increasing concentrations of bicuculline 
(i.e. 1 X 1O-5-5 X 1 Op4 M) produced an inhibition of 
the binding of [ 14C] GABA of the order of 50-80.5%. 
4. Discussion 
Since, in 1967, De Robertis et al. [ 161 reported 
the isolation of a hydrophobic protein fraction (i.e. 
proteolipid) from cerebral cortex binding cholinergic 
ligands considerable progress has been made in the 
isolation and characterization of central and peripheral 
receptors (see [20]). Most work has been carried out 
on the electric tissue of the Electrophorus and 
Torpedo using either organic solvents [2 l] or deter- 
gents for solubilization of receptor proteins [ 15, 221. 
With organic solvents a cholinergic receptor fraction 
was isolated from skeletal muscle [23] and adrenergic 
binding proteins were separated from spleen [24] and 
heart [25]. More recently a muscarinic binding protein 
was isolated from the circular layer of the intestine [26]. 
Regarding amino acid binding proteins, to our 
knowledge, the only work is that of Lunt [ 141 who 
used muscles of the locust (Shistocerca gregaria). He 
extracted a crude detergent solubilized protein that by 
equilibrium dialysis showed high affinity for glutamate 
and practically no binding for glutamine or aspartate. 
Using organic solvent extraction [ 161, followed by 
Sephadex LH-20 chromatography, he found two pro- 
tein fractions showing specific binding for glutamate. 
He concluded that these hydrophobic proteins could 
constitute part of the glutamate receptor at the insect 
neuromuscular junction. 
The results here described suggest hat in shrimp 
muscle both glutamate and GABA bind to two distinct 
hydrophobic protein fractions which can be separated 
by their chromatographic characteristics and also by 
their different properties regarding the diethyl-ether 
precipitation. The maximal amount of protein binding 
glutamate corresponds to 27 pg/g, a figure that is con- 
siderably lower than that given by Lunt [ 141 for the 
locust. The degree of purification achieved in our case 
is higher than 900-fold, since in the total sediment 
used for the extraction we had 25.6 mg total protein. 
Our glutamate-binding protein saturates at 1 mole per 
320 000 g and does not bind GABA, aspartate or 
glutamine. The GABA receptor protein appeared in a 
better defined peak, without lipid phosphorus, and at 
a concentration of 2 1.5 kg/g which corresponds to a 
purification of about 1200 times. Here the saturation 
is achieved at 1 mole per 80 000 g of protein. The 
specificity of this protein fraction was demonstrated 
by the lack of binding of glutamate, glutamine, as- 
partate and by the competition with the specific 
inhibitor bicuculline. Further work is being conducted 
to better ascertain the specificity of the binding of 
glutamate and GABA with the use of other competi- 
tors, to separate receptor proteins from other species 
and to obtain information about the size and nature 
of the macromolecules involved in the specific binding 
of these amino acids. 
The work done so far permits us to conclude that the 
two hydrophobic proteins isolated from shrimp muscle 
have some of the properties that are characteristic of 
receptors for glutamate and GABA. 
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